Skin appendage carcinoma
MONDO:0006973A carcinoma arising from the sebaceous glands, sweat glands, or the hair follicles. Representative examples include sebaceous carcinoma, apocrine carcinoma, eccrine carcinoma, and pilomatrical carcinoma.
Also known as: adnexal carcinoma, carcinoma of adnexa, carcinoma of cutaneous appendage, carcinoma of skin appendage, carcinoma, adnexal, malignant, cutaneous appendage carcinoma, skin appendage carcinoma, skin adnexal carcinoma
2768 clinical trials for this condition and its sub-types, 4 tagged with Skin appendage carcinoma itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Skin appendage carcinoma
-
Sebaceous adenocarcinoma 2 trials · 3 incl. sub-types
3 sub-types
- Ocular sebaceous carcinoma 1 trial · 2 incl. sub-types Sub-types →
- Sebaceous breast carcinoma 0 trials
- Vulvar sebaceous carcinoma 0 trials
-
Sweat gland carcinoma 1 trial · 2 incl. sub-types
4 sub-types
- Apocrine adenocarcinoma 2 trials Sub-types →
- Eccrine carcinoma 0 trials · 1 incl. sub-types Sub-types →
- Hidradenocarcinoma 1 trial Sub-types →
- Cutaneous adenocystic carcinoma 0 trials
-
Skin pilomatrix carcinoma 0 trials
Most studied deeper sub-types
-
New virus therapy takes on advanced cancers in first human trial
Disease control Recruiting nowThis early-phase study tests a new treatment called MQ710, a modified virus injected directly into tumors, alone or with the immunotherapy drug pembrolizumab. It is for people with advanced solid tumors (like skin cancer or head and neck cancer) that have not responded to standar…
Phase 1 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC
-
New database aims to crack the code on three rare skin cancers
Knowledge-focused Recruiting nowThis study is building a large French database of patients with three rare skin cancers: Merkel cell carcinoma, advanced basal cell carcinoma, and cutaneous adnexal carcinomas. Researchers will track up to 9,000 participants to learn how these cancers behave, what factors affect …
Sponsor: University Hospital, Lille • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:37 UTC